Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatropin for diaphragm function and ventilator weaning
IRCT20230626058586N10Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of somatropin in Diaphragmatic dysfunction (DD) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Weaning and Diaphragm thickness. Started Feb 2025; status: completed.
02
Drugs
somatropin
03
Conditions
Diaphragmatic dysfunction (DD)
Beyond the preview
Go deeper on IRCT20230626058586N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230626058586N10.